Incyte Corporation (NASDAQ:INCY) and Eli Lilly and Company (NYSE:LLY) announced positive topline results of RA-BEAM, the fourth successful Phase 3 study of baricitinib, an …
Incyte Corporation (NASDAQ:INCY) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the expansion of the companies’ ongoing clinical …
Incyte Corporation (NASDAQ:INCY) announces that new data from its investigational immuno-oncology portfolio will be presented at the upcoming Society for Immunotherapy of Cancer (SITC) …
Incyte Corporation (NASDAQ:INCY) and Eli Lilly and Company (NYSE:LLY) announced positive top-line results of RA-BEGIN, the third Phase 3 study evaluating the safety and …
Recently, various executives have taken part in insider selling activity for the stocks of Athersys, Inc.(NASDAQ:ATHX), Neuralstem, Inc.
After the market close on September 11th, Gilead Sciences, Inc. (NASDAQ:GILD) announced that it had raised $9.
In a research report released today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on shares of Incyte Corporation (NASDAQ:INCY) with a price …
J.P.
Incyte Corporation (NASDAQ:INCY) announced a global license and collaboration agreement with Jiangsu Hengrui Medicine Co., Ltd.
In a research report released Tuesday, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on shares of Incyte Corporation (NASDAQ:INCY) with a price target of …
